FDA Seeks Public Input on Rare Disease Innovation Workshops
January 30, 2026
January 30, 2026
WASHINGTON, Jan. 30 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration is seeking public input to shape a series of meetings focused on advancing treatments for rare conditions. The agency announced a request for comments to help identify topics for its Rare Disease Innovation, Science and Exploration (RISE) Workshop series.
The RISE workshops aim to address scientific hurdles that affect multiple diseases rather than focusing on specific produc . . .
The RISE workshops aim to address scientific hurdles that affect multiple diseases rather than focusing on specific produc . . .